Skip to content
10-Q

Quarterly Report

LAVA Therapeutics NV

0001104659-25-107725

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 26.31M sh
Shares Diluted Q3 2025 · Sep 30, 2025 26.9M sh
Shares Diluted Q3 2025 · Sep 30, 2025 26.9M sh
Shares Diluted Q3 2025 · Sep 30, 2024 26.85M sh
Shares Diluted Q3 2025 · Sep 30, 2024 26.82M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$30.26M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$19.05M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $49.66M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $35.02M
Stockholders Equity Q3 2025 · Sep 30, 2025 $12.68M
Stockholders Equity Q3 2025 · Jun 30, 2025 $19.94M
Stockholders Equity Q3 2025 · Mar 31, 2025 $25.78M
Stockholders Equity Q3 2025 · Dec 31, 2024 $27.75M
Stockholders Equity Q3 2025 · Sep 30, 2024 $33.04M
Stockholders Equity Q3 2025 · Jun 30, 2024 $42.92M
Stockholders Equity Q3 2025 · Mar 31, 2024 $50.81M
Stockholders Equity Q3 2025 · Dec 31, 2023 $51.36M
Current Liabilities Q3 2025 · Sep 30, 2025 $4.23M
Current Liabilities Q3 2025 · Dec 31, 2024 $18.01M
Total Liabilities Q3 2025 · Sep 30, 2025 $39.23M
Total Liabilities Q3 2025 · Dec 31, 2024 $53.09M
Current Assets Q3 2025 · Sep 30, 2025 $51.91M
Current Assets Q3 2025 · Dec 31, 2024 $79.3M
Total Assets Q3 2025 · Sep 30, 2025 $51.92M
Total Assets Q3 2025 · Dec 31, 2024 $80.83M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.27
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.72
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.46
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.79
Eps Basic Q3 2025 · Sep 30, 2025 −$0.27
Eps Basic Q3 2025 · Sep 30, 2025 −$0.72
Eps Basic Q3 2025 · Sep 30, 2024 −$0.46
Eps Basic Q3 2025 · Sep 30, 2024 −$0.79
Sga Expense Q3 2025 · Sep 30, 2025 $5.31M
Sga Expense Q3 2025 · Sep 30, 2025 $11.3M
Sga Expense Q3 2025 · Sep 30, 2024 $3.07M
Sga Expense Q3 2025 · Sep 30, 2024 $9.88M
Rd Expense Q3 2025 · Sep 30, 2025 $2.24M
Rd Expense Q3 2025 · Sep 30, 2025 $11.13M
Rd Expense Q3 2025 · Sep 30, 2024 $8.28M
Rd Expense Q3 2025 · Sep 30, 2024 $19.88M
Net Income Q3 2025 · Sep 30, 2025 −$7.19M
Net Income Q3 2025 · Sep 30, 2025 −$19.31M
Net Income Q3 2025 · Jun 30, 2025 −$8.64M
Net Income Q3 2025 · Mar 31, 2025 −$3.48M
Net Income Q3 2025 · Sep 30, 2024 −$12.33M
Net Income Q3 2025 · Sep 30, 2024 −$21.24M
Net Income Q3 2025 · Jun 30, 2024 −$8.3M
Net Income Q3 2025 · Mar 31, 2024 −$608K
Operating Income Q3 2025 · Sep 30, 2025 −$7.55M
Operating Income Q3 2025 · Sep 30, 2025 −$22.43M
Operating Income Q3 2025 · Sep 30, 2024 −$11.34M
Operating Income Q3 2025 · Sep 30, 2024 −$22.77M
Short Term Debt Q3 2025 · Dec 31, 2024 $4.89M
Short Term Investments Q3 2025 · Dec 31, 2024 $41.56M
Capex Q3 2025 · Sep 30, 2024 $23K
Revenue Q3 2025 · Sep 30, 2024 $6.99M